Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Deep Learning Enabled 3D Multi-Omic Analysis Reveals Molecular Signatures of Heterogeneous Response to Chemotherapy in Pancreatic Cancer.
Journal: bioRxiv : the preprint server for biology
Published: March 23, 2026
Pancreatic cancer-associated organ dysfunction promotes muscle autophagy and contributes to peripheral tissue wasting.
Journal: bioRxiv : the preprint server for biology
Published: March 11, 2026
Pancreatic cancer-restricted cryptic antigens are targets for T cell recognition.
Journal: Science (New York, N.Y.)
Published: May 08, 2025
Emerging Role of Targeted Therapy in Metastatic Pancreatic Adenocarcinoma.
Journal: Cancers
Published: November 14, 2022
Getting a handle on KRAS inhibitor resistance with hapten-mediated anti-tumor immunity.
Journal: Cancer cell
Published: September 13, 2022
A prime editor mouse to model a broad spectrum of somatic mutations in vivo.
Journal: Nature biotechnology
Published: July 15, 2022
Neoadjuvant Chemotherapy Is Associated with Altered Immune Cell Infiltration and an Anti-Tumorigenic Microenvironment in Resected Pancreatic Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 12, 2022
Lineage tracing reveals the phylodynamics, plasticity, and paths of tumor evolution.
Journal: Cell
Published: September 21, 2021
Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment.
Journal: Nature genetics
Published: August 28, 2021
Deciphering the immunopeptidome in vivo reveals new tumour antigens.
Journal: Nature
Published: June 30, 2021
Measuring kinetics and metastatic propensity of CTCs by blood exchange between mice.
Journal: Nature communications
Published: October 12, 2020
Last Updated: 09/26/2026